- Home
- ALXO vs MODV Comparison
ALXO vs MODV Comparison
Compare ALXO & MODV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALXO
- MODV
- Stock Information
- Founded
- ALXO 2015
- MODV 1996
- Country
- ALXO United States
- MODV United States
- Employees
- ALXO N/A
- MODV N/A
- Industry
- ALXO Biotechnology: Pharmaceutical Preparations
- MODV Transportation Services
- Sector
- ALXO Health Care
- MODV Consumer Discretionary
- Exchange
- ALXO Nasdaq
- MODV Nasdaq
- Market Cap
- ALXO 76.5M
- MODV 81.8M
- IPO Year
- ALXO 2020
- MODV N/A
- Fundamental
- Price
- ALXO $1.12
- MODV $5.05
- Analyst Decision
- ALXO Buy
- MODV Buy
- Analyst Count
- ALXO 6
- MODV 5
- Target Price
- ALXO $6.64
- MODV $18.20
- AVG Volume (30 Days)
- ALXO 769.2K
- MODV 634.6K
- Earning Date
- ALXO 03-06-2025
- MODV 03-04-2025
- Dividend Yield
- ALXO N/A
- MODV N/A
- EPS Growth
- ALXO N/A
- MODV N/A
- EPS
- ALXO N/A
- MODV N/A
- Revenue
- ALXO N/A
- MODV $2,787,619,000.00
- Revenue This Year
- ALXO N/A
- MODV $3.37
- Revenue Next Year
- ALXO N/A
- MODV $2.71
- P/E Ratio
- ALXO N/A
- MODV N/A
- Revenue Growth
- ALXO N/A
- MODV 3.16
- 52 Week Low
- ALXO $0.96
- MODV $3.64
- 52 Week High
- ALXO $17.83
- MODV $39.48
- Technical
- Relative Strength Index (RSI)
- ALXO 38.53
- MODV 38.32
- Support Level
- ALXO $1.00
- MODV $5.73
- Resistance Level
- ALXO $1.22
- MODV $6.09
- Average True Range (ATR)
- ALXO 0.09
- MODV 0.60
- MACD
- ALXO 0.00
- MODV 0.35
- Stochastic Oscillator
- ALXO 35.12
- MODV 54.23
About ALXO ALX Oncology Holdings Inc.
ALX Oncology Holdings Inc is a clinical-stage immuno-oncology company focused on helping patients fight cancer by developing a pipeline of product candidates based on expertise in protein engineering and oncology led by the CD47 blocker, evorpacept, currently in phase 1 and 2 clinical trials. Cancer cells leverage CD47, a cell surface protein, as a don't eat me signal to evade detection by the immune system. The company is developing a next-generation checkpoint inhibitor designed to have a high affinity for CD47 and to avoid the limitations caused by hematologic toxicities inherent in other CD47 blocking approaches.
About MODV ModivCare Inc.
ModivCare Inc is a technology-enabled healthcare services company that provides a suite of integrated supportive care solutions for payors and their members. The company is also a provider of non-emergency medical transportation, or NEMT, personal care, and remote patient monitoring, or RPM, solutions, which serve similar, highly vulnerable patient populations. Its operating segment includes NEMT, Personal Care, and Remote Patient Monitoring. The company generates maximum revenue from the NEMT segment.